Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q3 2019 Earnings Conference Call November 6, 2019 8:00 AM ET Company Participants Sarah Carmody - Executive Director, IR & Corporate Communications Anna Protopapas - President, CEO & Director Dirk Huebner - Chief Medical Officer Timothy Lowinger - Chief Science & Technology Officer Brian DeSchuytner - SVP, Finance & Product Strategy Conference Call Participants Jonathan Chang - SVB Leerink Earl DeSouza - H.C. Wainwright & Co. Boris Peaker - Cowen and Company Daniel W ...